Business Today
Subscribe
PMS TodayBudget 2025US NewsIndiaWeatherBT ShortsNRIEducationElection
BT GolfBT India 100BT Mindrush
Search
Advertisement
Business News
markets
stocks
Colinz Laboratories Ltd
Colinz Laboratories Ltd

Colinz Laboratories Ltd Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 1,843
Dec 05, 2025
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹42.00
₹0.00 (0.00%)
41.95Low
Today’s Performance
42.26High
36.11Low
52 Week’s Performance
88.70High

bt_logoStock Performance

  • 1 Day-%
  • 1 Week2.71%
  • 1 Month5.50%
  • 3 Months-2.33%
  • 6 Months-32.89%
  • 1 Year-31.71%
  • 3 Years-5.30%
  • 5 Years30.07%

bt_logoStock Summary

  • Face Value (₹)10.00
  • Beta0.58
  • 52-Week Low (₹)36.11
  • 52-Week High (₹)88.70
  • Price-to-Book (X)*1.61
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*41.58
  • Earnings Per Share (₹)1.01
  • Market Cap (₹ Cr.)*19.20
* Values as of last close price

bt_logoCOMPETITORS

BT TV

"We Share, Not Just Sell”: Putin Reveals India–Russia Defence Upgrade & Nuclear Plans | Exclusive5:31"We Share, Not Just Sell”: Putin Reveals India–Russia Defence Upgrade & Nuclear Plans | Exclusive
Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations7:17Ground Report From IGI Counters: Stranded Flyers Slam IndiGo Amid Widespread Cancellations
FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support5:04FM Sitharaman Clarifies Cess On Demerit Goods: Fungible Funds For Defence, Public Health Support
India–Russia Trade to Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership2:31India–Russia Trade To Cross $100 Billion Before 2030: PM Modi Fast-Tracks Economic Partnership
Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push11:22Russia Eyes Indian Workforce, New Trade Plan And Tariff Cuts In Major Economic Push
IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide3:48IndiGo CEO Pieter Elbers Admits Worst-Ever Disruption As Over 1,000 Flights Cancelled Nationwide
India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities2:42India & Russia Plan Faster Trade Routes, Digital Corridors & New Nuclear Opportunities
Passengers Angry Over IndiGo Delays, Complain Of No Information3:16Passengers Angry Over IndiGo Delays, Complain Of No Information
Vikram Misri: India–Russia to Accelerate FTA, Investment Treaty and Key Connectivity Negotiations1:58Vikram Misri: India–Russia To Accelerate FTA, Investment Treaty And Key Connectivity Negotiations
‘If US Can Buy Russian Fuel, Why Not India?’: Putin Challenges Trump’s Claim On Ukraine War3:01‘If US Can Buy Russian Fuel, Why Not India?’: Putin Challenges Trump’s Claim On Ukraine War
View more

bt_logoFAQ's

What was Colinz Laboratories Ltd share price previously?
Colinz Laboratories Ltd share price was down by 0.00% from the previous closing price of ₹42.00.
Who are peers of Colinz Laboratories Ltd?
The peers of Colinz Laboratories Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Torrent Pharmaceuticals Ltd, Cipla Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd, Zydus Lifesciences Ltd.
Who is/are the promoter/promoters of Colinz Laboratories Ltd?
The promotor/promotors of Colinz Laboratories Ltd are N K Menon, Bhavik Ashokkumar Shah, Baptist Benard Dias, Swapnil Jayesh Madiyar, Vijaya Mani, Falguni Kumawat.
What has been 52-week high of Colinz Laboratories Ltd stocks?
The highest price of Colinz Laboratories Ltd stock is ₹88.70 in the last 52-week.
What is the share price of Colinz Laboratories Ltd (COLINZ) today on BSE?
As on Dec 05, 2025 Colinz Laboratories Ltd (COLINZ)’s share price on BSE is Rs 42
What is the market cap of Colinz Laboratories Ltd (COLINZ)?
The current market capitalisation of Colinz Laboratories Ltd (COLINZ) is 19.20 crores
What is Colinz Laboratories Ltd Share symbol?
The symbol of Colinz Laboratories Ltd is .
What is the PE ratio of Colinz Laboratories Ltd (COLINZ)?
The current PE ratio of Colinz Laboratories Ltd (COLINZ) is 41.58.
What is the PB ratio of Colinz Laboratories Ltd (COLINZ)?
The current PB ratio of Colinz Laboratories Ltd (COLINZ) is 1.61.
Today’s High & Low share prices of Colinz Laboratories Ltd (COLINZ) on BSE?
Today, the share price of Colinz Laboratories Ltd (COLINZ) on BSE touched a high of Rs 42.26 and a low of Rs 41.95
What price did Colinz Laboratories Ltd (COLINZ) shares open on the BSE today?
On BSE, the share price of Colinz Laboratories Ltd (COLINZ) opened at Rs 41.95
What is the 52-week high of Colinz Laboratories Ltd (COLINZ)?
The 52-week high price of Colinz Laboratories Ltd (COLINZ) is Rs 88.70
What is the 52-week low of Colinz Laboratories Ltd (COLINZ)?
The 52-week low price of Colinz Laboratories Ltd (COLINZ) is Rs 36.11

bt_logoAbout Colinz Labs

Colinz Laboratories Ltd, incorporated in the year 1986, has its registered office in A-101 Pratik Industrial Estate, Mulund Goregaon Link Road, Mumbai, Maharashtra, 400078, 91-022-25668002/8003. The main industry in which Colinz Laboratories Ltd operates is Pharmaceuticals - Indian - Formulations.

Auditor/Auditors for Colinz Laboratories Ltd is/are Vora & Associates. In the main management, is chairman and Falguni Kumawat is the company secretary for Colinz Laboratories Ltd.

  • NKM
    N K MenonED / WTD / CEO / Non Promoter
  • BAS
    Bhavik Ashokkumar ShahIndependent Non Exe. Director
  • BBD
    Baptist Benard DiasIndependent Non Exe. Director
  • SJM
    Swapnil Jayesh MadiyarNon-Exec & Non-Independent Dir
  • VM
    Vijaya ManiAdditional Director
  • FK
    Falguni KumawatCompany Sec. & Compli. Officer

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.